

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 6.18802780 |
| 2 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.84460920 |
| 3 | negative regulation of cell killing (GO:0031342) | 5.84460920 |
| 4 | detection of other organism (GO:0098543) | 4.86759862 |
| 5 | detection of bacterium (GO:0016045) | 4.79663132 |
| 6 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.60401383 |
| 7 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.58687900 |
| 8 | positive regulation by symbiont of host defense response (GO:0052509) | 4.56270448 |
| 9 | modulation by symbiont of host defense response (GO:0052031) | 4.56270448 |
| 10 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.56270448 |
| 11 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.56270448 |
| 12 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.56270448 |
| 13 | modulation by symbiont of host immune response (GO:0052553) | 4.56270448 |
| 14 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 4.53879006 |
| 15 | regulation of gamma-delta T cell activation (GO:0046643) | 4.49944378 |
| 16 | positive thymic T cell selection (GO:0045059) | 4.29596194 |
| 17 | B cell receptor signaling pathway (GO:0050853) | 4.27575384 |
| 18 | leukocyte aggregation (GO:0070486) | 4.14997705 |
| 19 | neutrophil activation involved in immune response (GO:0002283) | 4.13905793 |
| 20 | negative regulation of leukocyte mediated immunity (GO:0002704) | 4.01318815 |
| 21 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.00538442 |
| 22 | detection of external biotic stimulus (GO:0098581) | 3.97380140 |
| 23 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.96364557 |
| 24 | negative regulation of T cell mediated immunity (GO:0002710) | 3.96224603 |
| 25 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.82927743 |
| 26 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.82927743 |
| 27 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.77693453 |
| 28 | macrophage activation involved in immune response (GO:0002281) | 3.75884254 |
| 29 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.74578818 |
| 30 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.73619955 |
| 31 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.69494211 |
| 32 | positive regulation of B cell differentiation (GO:0045579) | 3.65908196 |
| 33 | negative thymic T cell selection (GO:0045060) | 3.62785866 |
| 34 | response to muramyl dipeptide (GO:0032495) | 3.59103807 |
| 35 | negative T cell selection (GO:0043383) | 3.56042829 |
| 36 | regulation of mast cell degranulation (GO:0043304) | 3.51146444 |
| 37 | type I interferon signaling pathway (GO:0060337) | 3.50902768 |
| 38 | cellular response to type I interferon (GO:0071357) | 3.50902768 |
| 39 | regulation of B cell differentiation (GO:0045577) | 3.50026939 |
| 40 | response to type I interferon (GO:0034340) | 3.48617732 |
| 41 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.46370320 |
| 42 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.46370320 |
| 43 | detection of biotic stimulus (GO:0009595) | 3.45800451 |
| 44 | regulation of tolerance induction (GO:0002643) | 3.45772566 |
| 45 | detection of molecule of bacterial origin (GO:0032490) | 3.45273953 |
| 46 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.44194716 |
| 47 | leukocyte cell-cell adhesion (GO:0007159) | 3.43942557 |
| 48 | negative regulation of interleukin-12 production (GO:0032695) | 3.43062229 |
| 49 | neutrophil activation (GO:0042119) | 3.41945326 |
| 50 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.39207618 |
| 51 | cell adhesion mediated by integrin (GO:0033627) | 3.36565447 |
| 52 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.35264144 |
| 53 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.34502828 |
| 54 | respiratory burst (GO:0045730) | 3.34106059 |
| 55 | microglial cell activation (GO:0001774) | 3.33469435 |
| 56 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.32800923 |
| 57 | positive T cell selection (GO:0043368) | 3.31864477 |
| 58 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.31714594 |
| 59 | tolerance induction (GO:0002507) | 3.28577194 |
| 60 | granulocyte activation (GO:0036230) | 3.26524363 |
| 61 | leukocyte degranulation (GO:0043299) | 3.23819237 |
| 62 | thymic T cell selection (GO:0045061) | 3.23419738 |
| 63 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.23217719 |
| 64 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.22444586 |
| 65 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.21125022 |
| 66 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.21021797 |
| 67 | regulation of regulatory T cell differentiation (GO:0045589) | 3.18064679 |
| 68 | positive regulation of mast cell activation (GO:0033005) | 3.16451813 |
| 69 | response to peptidoglycan (GO:0032494) | 3.14206682 |
| 70 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.14180741 |
| 71 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.13554903 |
| 72 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.13554903 |
| 73 | myeloid cell activation involved in immune response (GO:0002275) | 3.13267187 |
| 74 | negative regulation of innate immune response (GO:0045824) | 3.12622955 |
| 75 | T cell migration (GO:0072678) | 3.12097703 |
| 76 | NIK/NF-kappaB signaling (GO:0038061) | 3.11622115 |
| 77 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.10943665 |
| 78 | cellular extravasation (GO:0045123) | 3.10760863 |
| 79 | response to host (GO:0075136) | 3.10616082 |
| 80 | response to host defenses (GO:0052200) | 3.10616082 |
| 81 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.10616082 |
| 82 | response to laminar fluid shear stress (GO:0034616) | 3.10483926 |
| 83 | heterotypic cell-cell adhesion (GO:0034113) | 3.10322440 |
| 84 | regulation of leukocyte degranulation (GO:0043300) | 3.10134750 |
| 85 | macrophage activation (GO:0042116) | 3.09902000 |
| 86 | positive regulation of granulocyte differentiation (GO:0030854) | 3.06995462 |
| 87 | T cell selection (GO:0045058) | 3.05424294 |
| 88 | regulation of mast cell activation (GO:0033003) | 3.03209290 |
| 89 | B cell mediated immunity (GO:0019724) | 3.02621664 |
| 90 | response to host immune response (GO:0052572) | 3.02485514 |
| 91 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.02485514 |
| 92 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 3.01495175 |
| 93 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.01226308 |
| 94 | substrate-dependent cell migration (GO:0006929) | 3.00913410 |
| 95 | germinal center formation (GO:0002467) | 2.99307675 |
| 96 | positive regulation of tolerance induction (GO:0002645) | 2.98858117 |
| 97 | negative regulation of alpha-beta T cell activation (GO:0046636) | 2.96892203 |
| 98 | response to interleukin-15 (GO:0070672) | 2.94376324 |
| 99 | positive regulation of interferon-alpha production (GO:0032727) | 2.92567182 |
| 100 | cortical actin cytoskeleton organization (GO:0030866) | 2.92347314 |
| 101 | positive regulation of antigen processing and presentation (GO:0002579) | 2.91864485 |
| 102 | B cell homeostasis (GO:0001782) | 2.91355369 |
| 103 | mature B cell differentiation (GO:0002335) | 2.90542548 |
| 104 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.90173720 |
| 105 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.88585335 |
| 106 | regulation of antigen processing and presentation (GO:0002577) | 2.88300965 |
| 107 | regulation of interferon-alpha production (GO:0032647) | 2.86980363 |
| 108 | immunoglobulin mediated immune response (GO:0016064) | 2.82559134 |
| 109 | neutrophil mediated immunity (GO:0002446) | 2.81522752 |
| 110 | I-kappaB phosphorylation (GO:0007252) | 2.80764177 |
| 111 | negative regulation of phagocytosis (GO:0050765) | 2.78729809 |
| 112 | negative regulation of B cell proliferation (GO:0030889) | 2.76882155 |
| 113 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.75857918 |
| 114 | pinocytosis (GO:0006907) | 2.75028193 |
| 115 | positive regulation of macrophage differentiation (GO:0045651) | 2.64905393 |
| 116 | negative regulation of interleukin-6 production (GO:0032715) | 2.62925398 |
| 117 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.61149438 |
| 118 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.58416465 |
| 119 | response to protozoan (GO:0001562) | 2.57885459 |
| 120 | positive regulation of isotype switching (GO:0045830) | 2.57725562 |
| 121 | T cell costimulation (GO:0031295) | 2.56837891 |
| 122 | cortical cytoskeleton organization (GO:0030865) | 2.56365070 |
| 123 | T cell receptor signaling pathway (GO:0050852) | 2.56176100 |
| 124 | immune response-activating cell surface receptor signaling pathway (GO:0002429) | 2.55910597 |
| 125 | lymphocyte homeostasis (GO:0002260) | 2.55685186 |
| 126 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.54488206 |
| 127 | interferon-gamma production (GO:0032609) | 2.54227344 |
| 128 | integrin-mediated signaling pathway (GO:0007229) | 2.53647779 |
| 129 | B cell proliferation (GO:0042100) | 2.53551767 |
| 130 | cellular response to interleukin-15 (GO:0071350) | 2.53284498 |
| 131 | regulation of T cell tolerance induction (GO:0002664) | 2.51974941 |
| 132 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.51633755 |
| 133 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 2.51445811 |
| 134 | lymphocyte costimulation (GO:0031294) | 2.51012716 |
| 135 | germ cell migration (GO:0008354) | 2.50997498 |
| 136 | modulation by symbiont of host cellular process (GO:0044068) | 2.50692477 |
| 137 | activated T cell proliferation (GO:0050798) | 2.50593421 |
| 138 | myeloid leukocyte activation (GO:0002274) | 2.50134279 |
| 139 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.49159010 |
| 140 | positive regulation of cell adhesion mediated by integrin (GO:0033630) | 2.47709289 |
| 141 | defense response to protozoan (GO:0042832) | 2.47213930 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 5.09328040 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.14497168 |
| 3 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.10481713 |
| 4 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.95223546 |
| 5 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.53623799 |
| 6 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.40052633 |
| 7 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.38878390 |
| 8 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.34292857 |
| 9 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.33694212 |
| 10 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.04797109 |
| 11 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.93705369 |
| 12 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.91619678 |
| 13 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.90058141 |
| 14 | MYC_22102868_ChIP-Seq_BL_Human | 2.83833063 |
| 15 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.77026453 |
| 16 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.64720280 |
| 17 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.60681060 |
| 18 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.57015608 |
| 19 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.54829841 |
| 20 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.51232199 |
| 21 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.38969514 |
| 22 | MYB_26560356_Chip-Seq_TH2_Human | 2.35246513 |
| 23 | MAF_26560356_Chip-Seq_TH1_Human | 2.34691163 |
| 24 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.32912055 |
| 25 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.25886602 |
| 26 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 2.23613397 |
| 27 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.23605527 |
| 28 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.17108649 |
| 29 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.15980890 |
| 30 | UTX_26944678_Chip-Seq_JUKART_Human | 2.15692565 |
| 31 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.12810708 |
| 32 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.11470019 |
| 33 | SPI1_23127762_ChIP-Seq_K562_Human | 2.11300251 |
| 34 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.11266811 |
| 35 | MYB_26560356_Chip-Seq_TH1_Human | 2.07981119 |
| 36 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.07443873 |
| 37 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.06987561 |
| 38 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.05048430 |
| 39 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.01856658 |
| 40 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.97162876 |
| 41 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.94139976 |
| 42 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.92205809 |
| 43 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.89481507 |
| 44 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.85558007 |
| 45 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.78387193 |
| 46 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.69157082 |
| 47 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.59814794 |
| 48 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.55429304 |
| 49 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.52806545 |
| 50 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.48501073 |
| 51 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.47476572 |
| 52 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.44723185 |
| 53 | MAF_26560356_Chip-Seq_TH2_Human | 1.44137138 |
| 54 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.40856103 |
| 55 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.39514428 |
| 56 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.38972268 |
| 57 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.32546897 |
| 58 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.31874573 |
| 59 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.31166829 |
| 60 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.29354746 |
| 61 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.29290797 |
| 62 | * VDR_24787735_ChIP-Seq_THP-1_Human | 1.28411898 |
| 63 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.26003142 |
| 64 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.25637084 |
| 65 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.23475698 |
| 66 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.23267278 |
| 67 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.22895176 |
| 68 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.20771129 |
| 69 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.19485305 |
| 70 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.17703957 |
| 71 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.17177396 |
| 72 | GATA1_19941826_ChIP-Seq_K562_Human | 1.16870999 |
| 73 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.16730536 |
| 74 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.16018866 |
| 75 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.14682283 |
| 76 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.13702939 |
| 77 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.13296070 |
| 78 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.13103214 |
| 79 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.13084649 |
| 80 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.12286221 |
| 81 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.12072866 |
| 82 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.08768254 |
| 83 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.07778437 |
| 84 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.07468519 |
| 85 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.05998418 |
| 86 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.05877958 |
| 87 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.05429488 |
| 88 | GATA2_19941826_ChIP-Seq_K562_Human | 1.03928955 |
| 89 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.03868641 |
| 90 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.02704420 |
| 91 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.02704420 |
| 92 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.02493414 |
| 93 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.01675563 |
| 94 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.01608807 |
| 95 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.01239186 |
| 96 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.00673604 |
| 97 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.99629983 |
| 98 | GATA3_26560356_Chip-Seq_TH2_Human | 0.97475437 |
| 99 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.95328967 |
| 100 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.95295828 |
| 101 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.95294665 |
| 102 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.94402442 |
| 103 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.94388943 |
| 104 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.93346427 |
| 105 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.92024002 |
| 106 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.91929369 |
| 107 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.91570144 |
| 108 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.90339654 |
| 109 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.89930875 |
| 110 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.88434438 |
| 111 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.87551605 |
| 112 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.87147109 |
| 113 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.85454807 |
| 114 | * PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.85451960 |
| 115 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.84674903 |
| 116 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.83894061 |
| 117 | * GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.83744744 |
| 118 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.83320973 |
| 119 | P68_20966046_ChIP-Seq_HELA_Human | 0.82419697 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003303_peritoneal_inflammation | 3.67531357 |
| 2 | MP0001835_abnormal_antigen_presentation | 3.22268726 |
| 3 | MP0003300_gastrointestinal_ulcer | 3.13212428 |
| 4 | MP0003436_decreased_susceptibility_to | 2.95465283 |
| 5 | MP0000685_abnormal_immune_system | 2.93260372 |
| 6 | MP0000569_abnormal_digit_pigmentation | 2.91496690 |
| 7 | MP0001790_abnormal_immune_system | 2.87655494 |
| 8 | MP0005387_immune_system_phenotype | 2.87655494 |
| 9 | MP0001800_abnormal_humoral_immune | 2.83763046 |
| 10 | MP0005000_abnormal_immune_tolerance | 2.66714948 |
| 11 | MP0002452_abnormal_antigen_presenting | 2.63913161 |
| 12 | MP0002419_abnormal_innate_immunity | 2.59010502 |
| 13 | MP0005058_abnormal_lysosome_morphology | 2.48599994 |
| 14 | MP0002723_abnormal_immune_serum | 2.41618018 |
| 15 | MP0005671_abnormal_response_to | 2.40122523 |
| 16 | MP0009278_abnormal_bone_marrow | 2.37745521 |
| 17 | MP0002420_abnormal_adaptive_immunity | 2.36643000 |
| 18 | MP0005464_abnormal_platelet_physiology | 2.36486571 |
| 19 | MP0001819_abnormal_immune_cell | 2.34615308 |
| 20 | MP0005025_abnormal_response_to | 2.27441323 |
| 21 | MP0009785_altered_susceptibility_to | 2.21716936 |
| 22 | MP0003172_abnormal_lysosome_physiology | 2.21346931 |
| 23 | MP0006082_CNS_inflammation | 2.16308158 |
| 24 | MP0004947_skin_inflammation | 2.07613674 |
| 25 | MP0002405_respiratory_system_inflammati | 2.06080761 |
| 26 | MP0003566_abnormal_cell_adhesion | 2.04463489 |
| 27 | MP0002398_abnormal_bone_marrow | 2.02829355 |
| 28 | MP0004510_myositis | 1.99949098 |
| 29 | MP0003763_abnormal_thymus_physiology | 1.93341616 |
| 30 | MP0008260_abnormal_autophagy | 1.93220609 |
| 31 | MP0010352_gastrointestinal_tract_polyps | 1.93203911 |
| 32 | MP0000716_abnormal_immune_system | 1.89708920 |
| 33 | MP0000689_abnormal_spleen_morphology | 1.79415423 |
| 34 | MP0002148_abnormal_hypersensitivity_rea | 1.78670496 |
| 35 | MP0001533_abnormal_skeleton_physiology | 1.78040796 |
| 36 | MP0002166_altered_tumor_susceptibility | 1.76996081 |
| 37 | MP0009333_abnormal_splenocyte_physiolog | 1.76879312 |
| 38 | MP0002132_abnormal_respiratory_system | 1.76693212 |
| 39 | MP0002933_joint_inflammation | 1.74287907 |
| 40 | MP0004808_abnormal_hematopoietic_stem | 1.72552640 |
| 41 | MP0002396_abnormal_hematopoietic_system | 1.70019055 |
| 42 | MP0000465_gastrointestinal_hemorrhage | 1.68812837 |
| 43 | MP0003091_abnormal_cell_migration | 1.68591265 |
| 44 | MP0002722_abnormal_immune_system | 1.65105944 |
| 45 | MP0003448_altered_tumor_morphology | 1.61373712 |
| 46 | MP0010155_abnormal_intestine_physiology | 1.61343819 |
| 47 | MP0001845_abnormal_inflammatory_respons | 1.60997057 |
| 48 | MP0004381_abnormal_hair_follicle | 1.60678717 |
| 49 | MP0002277_abnormal_respiratory_mucosa | 1.55985995 |
| 50 | MP0001853_heart_inflammation | 1.55966720 |
| 51 | MP0002429_abnormal_blood_cell | 1.54285817 |
| 52 | MP0005023_abnormal_wound_healing | 1.53222508 |
| 53 | MP0001873_stomach_inflammation | 1.51431683 |
| 54 | MP0000858_altered_metastatic_potential | 1.49249705 |
| 55 | MP0002006_tumorigenesis | 1.40770505 |
| 56 | MP0000703_abnormal_thymus_morphology | 1.40331013 |
| 57 | MP0005174_abnormal_tail_pigmentation | 1.40011325 |
| 58 | MP0005397_hematopoietic_system_phenotyp | 1.39977248 |
| 59 | MP0001545_abnormal_hematopoietic_system | 1.39977248 |
| 60 | MP0002998_abnormal_bone_remodeling | 1.36638201 |
| 61 | MP0003279_aneurysm | 1.34398145 |
| 62 | MP0003045_fibrosis | 1.32858102 |
| 63 | MP0001851_eye_inflammation | 1.29020068 |
| 64 | MP0004883_abnormal_blood_vessel | 1.26820610 |
| 65 | MP0003183_abnormal_peptide_metabolism | 1.25310373 |
| 66 | MP0001958_emphysema | 1.24013167 |
| 67 | MP0005451_abnormal_body_composition | 1.22515815 |
| 68 | MP0005076_abnormal_cell_differentiation | 1.21508443 |
| 69 | MP0008438_abnormal_cutaneous_collagen | 1.18973904 |
| 70 | MP0003724_increased_susceptibility_to | 1.16499980 |
| 71 | MP0001986_abnormal_taste_sensitivity | 1.15830878 |
| 72 | MP0000604_amyloidosis | 1.13134615 |
| 73 | MP0003866_abnormal_defecation | 1.09500607 |
| 74 | MP0008469_abnormal_protein_level | 1.08732704 |
| 75 | MP0005075_abnormal_melanosome_morpholog | 1.07615870 |
| 76 | MP0000733_abnormal_muscle_development | 1.07031131 |
| 77 | MP0010307_abnormal_tumor_latency | 1.06199568 |
| 78 | MP0003453_abnormal_keratinocyte_physiol | 0.99689634 |
| 79 | MP0002928_abnormal_bile_duct | 0.99601269 |
| 80 | MP0000490_abnormal_crypts_of | 0.96471462 |
| 81 | MP0003705_abnormal_hypodermis_morpholog | 0.95656480 |
| 82 | MP0000015_abnormal_ear_pigmentation | 0.95549712 |
| 83 | MP0009840_abnormal_foam_cell | 0.93095897 |
| 84 | MP0005390_skeleton_phenotype | 0.92533591 |
| 85 | MP0000920_abnormal_myelination | 0.90437550 |
| 86 | MP0006054_spinal_hemorrhage | 0.90204765 |
| 87 | MP0003075_altered_response_to | 0.89943104 |
| 88 | MP0001663_abnormal_digestive_system | 0.88849565 |
| 89 | MP0000343_altered_response_to | 0.86337211 |
| 90 | MP0005310_abnormal_salivary_gland | 0.86217690 |
| 91 | MP0005164_abnormal_response_to | 0.85785161 |
| 92 | MP0003191_abnormal_cellular_cholesterol | 0.85509730 |
| 93 | MP0005166_decreased_susceptibility_to | 0.82836888 |
| 94 | MP0000767_abnormal_smooth_muscle | 0.79614152 |
| 95 | MP0001348_abnormal_lacrimal_gland | 0.79246635 |
| 96 | MP0002138_abnormal_hepatobiliary_system | 0.79017319 |
| 97 | MP0000249_abnormal_blood_vessel | 0.78783200 |
| 98 | MP0003795_abnormal_bone_structure | 0.78714309 |
| 99 | MP0005623_abnormal_meninges_morphology | 0.74760223 |
| 100 | MP0005621_abnormal_cell_physiology | 0.73491694 |
| 101 | MP0001243_abnormal_dermal_layer | 0.72749600 |
| 102 | MP0002877_abnormal_melanocyte_morpholog | 0.70479249 |
| 103 | MP0009764_decreased_sensitivity_to | 0.70303761 |
| 104 | MP0001915_intracranial_hemorrhage | 0.70238074 |
| 105 | MP0004130_abnormal_muscle_cell | 0.69737833 |
| 106 | MP0009765_abnormal_xenobiotic_induced | 0.68082958 |
| 107 | MP0008004_abnormal_stomach_pH | 0.67672959 |
| 108 | MP0002019_abnormal_tumor_incidence | 0.67623093 |
| 109 | MP0005167_abnormal_blood-brain_barrier | 0.67152435 |
| 110 | MP0003690_abnormal_glial_cell | 0.64860854 |
| 111 | MP0002009_preneoplasia | 0.64822618 |
| 112 | MP0003828_pulmonary_edema | 0.64306374 |
| 113 | MP0009763_increased_sensitivity_to | 0.63430900 |
| 114 | MP0003656_abnormal_erythrocyte_physiolo | 0.63025916 |
| 115 | MP0002136_abnormal_kidney_physiology | 0.61266715 |
| 116 | MP0003221_abnormal_cardiomyocyte_apopto | 0.60278837 |
| 117 | MP0008874_decreased_physiological_sensi | 0.59303528 |
| 118 | MP0002168_other_aberrant_phenotype | 0.58601401 |
| 119 | MP0002693_abnormal_pancreas_physiology | 0.49766698 |
| 120 | MP0005377_hearing/vestibular/ear_phenot | 0.48847917 |
| 121 | MP0003878_abnormal_ear_physiology | 0.48847917 |
| 122 | MP0003806_abnormal_nucleotide_metabolis | 0.47554404 |
| 123 | MP0005381_digestive/alimentary_phenotyp | 0.46828739 |
| 124 | MP0002133_abnormal_respiratory_system | 0.44738391 |
| 125 | MP0005388_respiratory_system_phenotype | 0.44738391 |
| 126 | MP0005319_abnormal_enzyme/_coenzyme | 0.43799053 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 5.00195717 |
| 2 | Recurrent bacterial skin infections (HP:0005406) | 4.53201854 |
| 3 | Eczematoid dermatitis (HP:0000976) | 4.42980416 |
| 4 | Gastrointestinal infarctions (HP:0005244) | 4.27849833 |
| 5 | Encephalitis (HP:0002383) | 3.96282359 |
| 6 | Increased IgE level (HP:0003212) | 3.72016915 |
| 7 | Hypochromic microcytic anemia (HP:0004840) | 3.67303323 |
| 8 | Keratoconjunctivitis sicca (HP:0001097) | 3.61234857 |
| 9 | Recurrent fungal infections (HP:0002841) | 3.49891425 |
| 10 | Cellulitis (HP:0100658) | 3.48459634 |
| 11 | Recurrent viral infections (HP:0004429) | 3.44088644 |
| 12 | Hypochromic anemia (HP:0001931) | 3.43451716 |
| 13 | Keratoconjunctivitis (HP:0001096) | 3.39391124 |
| 14 | Urticaria (HP:0001025) | 3.38481133 |
| 15 | Stomatitis (HP:0010280) | 3.31982038 |
| 16 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.23640910 |
| 17 | Myositis (HP:0100614) | 3.22836791 |
| 18 | Increased cerebral lipofuscin (HP:0011813) | 3.18895758 |
| 19 | Recurrent skin infections (HP:0001581) | 3.13373395 |
| 20 | Abnormality of macrophages (HP:0004311) | 3.11609747 |
| 21 | Hemoptysis (HP:0002105) | 3.01463936 |
| 22 | Granulocytopenia (HP:0001913) | 2.97921373 |
| 23 | T lymphocytopenia (HP:0005403) | 2.94942216 |
| 24 | Increased IgM level (HP:0003496) | 2.94478607 |
| 25 | Mediastinal lymphadenopathy (HP:0100721) | 2.91821274 |
| 26 | Increased density of long bones (HP:0006392) | 2.91086126 |
| 27 | Episodic fever (HP:0001954) | 2.88198394 |
| 28 | Chronic obstructive pulmonary disease (HP:0006510) | 2.88074131 |
| 29 | Obstructive lung disease (HP:0006536) | 2.88074131 |
| 30 | Inflammation of the large intestine (HP:0002037) | 2.87131033 |
| 31 | Abnormality of T cell number (HP:0011839) | 2.84375248 |
| 32 | Colitis (HP:0002583) | 2.81196667 |
| 33 | Vacuolated lymphocytes (HP:0001922) | 2.80990020 |
| 34 | Cerebral aneurysm (HP:0004944) | 2.78075963 |
| 35 | Pustule (HP:0200039) | 2.75499502 |
| 36 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.75335986 |
| 37 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.74022289 |
| 38 | Gastrointestinal inflammation (HP:0004386) | 2.74011048 |
| 39 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.71379498 |
| 40 | Meningitis (HP:0001287) | 2.71179946 |
| 41 | Abnormality of T cell physiology (HP:0011840) | 2.68331412 |
| 42 | IgM deficiency (HP:0002850) | 2.68167768 |
| 43 | Abnormal platelet volume (HP:0011876) | 2.67587152 |
| 44 | Anorexia (HP:0002039) | 2.67214936 |
| 45 | Chronic otitis media (HP:0000389) | 2.66948114 |
| 46 | Pulmonary embolism (HP:0002204) | 2.65525200 |
| 47 | Agammaglobulinemia (HP:0004432) | 2.63994753 |
| 48 | Vasculitis (HP:0002633) | 2.63590402 |
| 49 | Recurrent cutaneous fungal infections (HP:0011370) | 2.63180082 |
| 50 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.63180082 |
| 51 | Orchitis (HP:0100796) | 2.60349801 |
| 52 | Periodontitis (HP:0000704) | 2.59818657 |
| 53 | Gingivitis (HP:0000230) | 2.59319323 |
| 54 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.56904515 |
| 55 | Osteolytic defects of the hand bones (HP:0009699) | 2.56904515 |
| 56 | Recurrent bronchitis (HP:0002837) | 2.55817272 |
| 57 | Petechiae (HP:0000967) | 2.55078985 |
| 58 | Interstitial pulmonary disease (HP:0006530) | 2.54941409 |
| 59 | Autoimmune thrombocytopenia (HP:0001973) | 2.53557268 |
| 60 | Aortic aneurysm (HP:0004942) | 2.52831998 |
| 61 | Absent frontal sinuses (HP:0002688) | 2.49524455 |
| 62 | Microcytic anemia (HP:0001935) | 2.48772403 |
| 63 | Optic neuritis (HP:0100653) | 2.48139063 |
| 64 | Retrobulbar optic neuritis (HP:0100654) | 2.48139063 |
| 65 | Osteomyelitis (HP:0002754) | 2.47953291 |
| 66 | Panhypogammaglobulinemia (HP:0003139) | 2.47615674 |
| 67 | Sepsis (HP:0100806) | 2.45572224 |
| 68 | Leukocytosis (HP:0001974) | 2.44233517 |
| 69 | Pulmonary infiltrates (HP:0002113) | 2.40688791 |
| 70 | Hypergammaglobulinemia (HP:0010702) | 2.38740941 |
| 71 | Increased mean platelet volume (HP:0011877) | 2.38676141 |
| 72 | Peritonitis (HP:0002586) | 2.37905922 |
| 73 | Aortic dissection (HP:0002647) | 2.36591893 |
| 74 | Thyroiditis (HP:0100646) | 2.33800902 |
| 75 | Abnormality of the pleura (HP:0002103) | 2.33531355 |
| 76 | Spondylolisthesis (HP:0003302) | 2.32574976 |
| 77 | Dysostosis multiplex (HP:0000943) | 2.29776798 |
| 78 | Abnormality of eosinophils (HP:0001879) | 2.29717507 |
| 79 | Persistence of primary teeth (HP:0006335) | 2.29109953 |
| 80 | Arterial tortuosity (HP:0005116) | 2.27117959 |
| 81 | Restrictive lung disease (HP:0002091) | 2.26914889 |
| 82 | Severe combined immunodeficiency (HP:0004430) | 2.24455827 |
| 83 | Premature rupture of membranes (HP:0001788) | 2.22377593 |
| 84 | Ulnar bowing (HP:0003031) | 2.21284967 |
| 85 | Papilloma (HP:0012740) | 2.21074377 |
| 86 | Verrucae (HP:0200043) | 2.21074377 |
| 87 | Gangrene (HP:0100758) | 2.20782541 |
| 88 | Disinhibition (HP:0000734) | 2.19466355 |
| 89 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.18158131 |
| 90 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.18158131 |
| 91 | Abnormality of glycolipid metabolism (HP:0010969) | 2.18158131 |
| 92 | Autoimmune hemolytic anemia (HP:0001890) | 2.16136235 |
| 93 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.15611183 |
| 94 | Abnormality of T cells (HP:0002843) | 2.15462682 |
| 95 | Prolonged bleeding time (HP:0003010) | 2.15321119 |
| 96 | Myocardial infarction (HP:0001658) | 2.14425974 |
| 97 | Nasal polyposis (HP:0100582) | 2.12562407 |
| 98 | Purpura (HP:0000979) | 2.11950976 |
| 99 | Lymphopenia (HP:0001888) | 2.11934038 |
| 100 | Vascular tortuosity (HP:0004948) | 2.11564808 |
| 101 | Hematochezia (HP:0002573) | 2.11497268 |
| 102 | Dilatation of the ascending aorta (HP:0005111) | 2.11276614 |
| 103 | Emphysema (HP:0002097) | 2.11241285 |
| 104 | Arterial thrombosis (HP:0004420) | 2.10893620 |
| 105 | Slow saccadic eye movements (HP:0000514) | 2.09893920 |
| 106 | IgG deficiency (HP:0004315) | 2.09344398 |
| 107 | Papilledema (HP:0001085) | 2.09173226 |
| 108 | Gastrointestinal stroma tumor (HP:0100723) | 2.08748879 |
| 109 | Glomerulopathy (HP:0100820) | 2.06352713 |
| 110 | Keratitis (HP:0000491) | 2.06256441 |
| 111 | Acute hepatic failure (HP:0006554) | 2.05851201 |
| 112 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.04739817 |
| 113 | Recurrent sinusitis (HP:0011108) | 2.04103262 |
| 114 | Axonal loss (HP:0003447) | 2.04021306 |
| 115 | Syringomyelia (HP:0003396) | 2.04004712 |
| 116 | Spinal cord lesions (HP:0100561) | 2.04004712 |
| 117 | Epistaxis (HP:0000421) | 2.02755306 |
| 118 | Amyloidosis (HP:0011034) | 2.02726549 |
| 119 | Abnormality of the peritoneum (HP:0002585) | 2.02171440 |
| 120 | Abnormal platelet function (HP:0011869) | 2.00926083 |
| 121 | Impaired platelet aggregation (HP:0003540) | 2.00926083 |
| 122 | Premature loss of primary teeth (HP:0006323) | 2.00133690 |
| 123 | Spontaneous hematomas (HP:0007420) | 1.99861366 |
| 124 | Thrombocytosis (HP:0001894) | 1.99717669 |
| 125 | Eosinophilia (HP:0001880) | 1.99402685 |
| 126 | Viral hepatitis (HP:0006562) | 1.99035027 |
| 127 | Abnormality of the endocardium (HP:0004306) | 1.97940519 |
| 128 | Broad face (HP:0000283) | 1.95170551 |
| 129 | Frequent falls (HP:0002359) | 1.94531713 |
| 130 | Gingival bleeding (HP:0000225) | 1.94184650 |
| 131 | Mitral valve prolapse (HP:0001634) | 1.94136267 |
| 132 | Abnormality of the fingertips (HP:0001211) | 1.94062834 |
| 133 | Increased serum ferritin (HP:0003281) | 1.93408956 |
| 134 | Joint swelling (HP:0001386) | 1.93100628 |
| 135 | Chest pain (HP:0100749) | 1.93051603 |
| 136 | Hepatosplenomegaly (HP:0001433) | 1.92303429 |
| 137 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.90265515 |
| 138 | Acne (HP:0001061) | 1.89113092 |
| 139 | Vertigo (HP:0002321) | 1.88246143 |
| 140 | Abnormality of iron homeostasis (HP:0011031) | 1.87370451 |
| 141 | Abnormality of the pericardium (HP:0001697) | 1.85776823 |
| 142 | Skin ulcer (HP:0200042) | 1.83597560 |
| 143 | Fatigue (HP:0012378) | 1.82083671 |
| 144 | Thick nail (HP:0001805) | 1.81844937 |
| 145 | Menorrhagia (HP:0000132) | 1.81364050 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 4.33598548 |
| 2 | TTN | 2.92170839 |
| 3 | STK10 | 2.50622844 |
| 4 | MAP3K14 | 2.45742569 |
| 5 | EPHB1 | 2.33933534 |
| 6 | PRPF4B | 2.28343574 |
| 7 | TYK2 | 2.21780953 |
| 8 | TRIB3 | 2.21098076 |
| 9 | TXK | 2.09566284 |
| 10 | TBK1 | 2.09560366 |
| 11 | JAK3 | 2.07537923 |
| 12 | BLK | 2.04151300 |
| 13 | MAP3K10 | 2.02176136 |
| 14 | RIPK4 | 2.00482783 |
| 15 | ITK | 1.91838571 |
| 16 | GRK6 | 1.87700252 |
| 17 | TGFBR2 | 1.84464285 |
| 18 | LRRK2 | 1.82267133 |
| 19 | HCK | 1.82236744 |
| 20 | EEF2K | 1.81098489 |
| 21 | ERN1 | 1.78770241 |
| 22 | KIT | 1.77090691 |
| 23 | JAK1 | 1.76834795 |
| 24 | CSF1R | 1.76228701 |
| 25 | IRAK4 | 1.75384704 |
| 26 | ZAP70 | 1.75312500 |
| 27 | CSK | 1.72569399 |
| 28 | BTK | 1.71933469 |
| 29 | PKN2 | 1.71420757 |
| 30 | SIK2 | 1.71265685 |
| 31 | IRAK3 | 1.62401977 |
| 32 | IKBKE | 1.59249582 |
| 33 | SIK3 | 1.56688784 |
| 34 | MAP3K13 | 1.56408932 |
| 35 | MAP3K11 | 1.53244446 |
| 36 | MAP3K3 | 1.49581689 |
| 37 | FES | 1.44482235 |
| 38 | SYK | 1.44188106 |
| 39 | TRPM7 | 1.41126552 |
| 40 | IKBKB | 1.39298395 |
| 41 | PTK6 | 1.39235936 |
| 42 | LCK | 1.38408319 |
| 43 | CAMK1D | 1.34145184 |
| 44 | CLK1 | 1.28346515 |
| 45 | CAMK1G | 1.26973470 |
| 46 | CDK12 | 1.15354630 |
| 47 | FGR | 1.12848935 |
| 48 | MAP2K3 | 1.09023715 |
| 49 | MAP3K1 | 1.05962958 |
| 50 | TEC | 1.02264909 |
| 51 | TAOK3 | 1.01957009 |
| 52 | KSR2 | 1.01909413 |
| 53 | RPS6KA4 | 0.97315331 |
| 54 | MARK3 | 0.96245248 |
| 55 | LYN | 0.93607608 |
| 56 | FGFR4 | 0.92614676 |
| 57 | YES1 | 0.91016351 |
| 58 | CDK19 | 0.88343857 |
| 59 | ALK | 0.88080429 |
| 60 | PIM1 | 0.87377468 |
| 61 | FGFR3 | 0.86863415 |
| 62 | PRKCH | 0.80148949 |
| 63 | BMX | 0.79380201 |
| 64 | IRAK1 | 0.77433455 |
| 65 | JAK2 | 0.77016044 |
| 66 | TESK2 | 0.75732698 |
| 67 | CHUK | 0.75681432 |
| 68 | PAK4 | 0.75568165 |
| 69 | RIPK1 | 0.72507053 |
| 70 | MAP3K6 | 0.71331965 |
| 71 | PDGFRB | 0.71199595 |
| 72 | MST4 | 0.70605744 |
| 73 | BMPR2 | 0.69453365 |
| 74 | DYRK1B | 0.69262642 |
| 75 | SMG1 | 0.69245407 |
| 76 | PRKCQ | 0.69094086 |
| 77 | TAOK2 | 0.68213147 |
| 78 | EGFR | 0.67781969 |
| 79 | PTK2 | 0.66159799 |
| 80 | CAMKK1 | 0.65597085 |
| 81 | PAK2 | 0.64413652 |
| 82 | DMPK | 0.64180157 |
| 83 | NLK | 0.61683058 |
| 84 | CAMKK2 | 0.61387853 |
| 85 | IRAK2 | 0.60171427 |
| 86 | CDC42BPA | 0.59269436 |
| 87 | ABL1 | 0.58787708 |
| 88 | MAPK7 | 0.58615384 |
| 89 | MAP3K8 | 0.58212224 |
| 90 | FYN | 0.58064690 |
| 91 | STK11 | 0.56326576 |
| 92 | MAP2K4 | 0.55074624 |
| 93 | MELK | 0.54383139 |
| 94 | CDK6 | 0.53548643 |
| 95 | STK38 | 0.51997099 |
| 96 | TNK2 | 0.51707980 |
| 97 | MARK2 | 0.50684850 |
| 98 | PDK1 | 0.49399222 |
| 99 | INSR | 0.49369263 |
| 100 | MAPKAPK2 | 0.49150121 |
| 101 | NEK9 | 0.48992101 |
| 102 | STK4 | 0.48859126 |
| 103 | PTK2B | 0.48842532 |
| 104 | MAP3K7 | 0.48544021 |
| 105 | RPS6KC1 | 0.46616403 |
| 106 | RPS6KL1 | 0.46616403 |
| 107 | MTOR | 0.46514962 |
| 108 | RET | 0.45138155 |
| 109 | MAP2K2 | 0.43646937 |
| 110 | EPHA3 | 0.42663305 |
| 111 | SGK3 | 0.40857685 |
| 112 | MATK | 0.40702636 |
| 113 | MAP3K5 | 0.40096500 |
| 114 | MOS | 0.39450815 |
| 115 | CDK9 | 0.38088184 |
| 116 | PRKD1 | 0.37902373 |
| 117 | RPS6KA6 | 0.37475139 |
| 118 | GRK7 | 0.37346749 |
| 119 | PDPK1 | 0.36940968 |
| 120 | SRC | 0.36331499 |
| 121 | TAOK1 | 0.36190645 |
| 122 | PIK3CG | 0.35278390 |
| 123 | PDGFRA | 0.35067071 |
| 124 | CDK4 | 0.34917161 |
| 125 | PRKG2 | 0.34610149 |
| 126 | MAP2K6 | 0.34333775 |
| 127 | PKN1 | 0.33626800 |
| 128 | HIPK2 | 0.33625872 |
| 129 | RAF1 | 0.33344355 |
| 130 | PRKD2 | 0.33161915 |
| 131 | PASK | 0.32472099 |
| 132 | SIK1 | 0.32348782 |
| 133 | MAPK12 | 0.32113965 |
| 134 | SCYL2 | 0.31508835 |
| 135 | MAP3K2 | 0.29685837 |
| 136 | MAPK11 | 0.28008427 |
| 137 | SGK2 | 0.26970152 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.79009362 |
| 2 | Leishmaniasis_Homo sapiens_hsa05140 | 2.63859893 |
| 3 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.51654897 |
| 4 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.41072166 |
| 5 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.15063062 |
| 6 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 2.10189034 |
| 7 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.99498670 |
| 8 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.87807175 |
| 9 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.87511531 |
| 10 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.85588301 |
| 11 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.79338000 |
| 12 | Measles_Homo sapiens_hsa05162 | 1.77365146 |
| 13 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.77139445 |
| 14 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.74854164 |
| 15 | Shigellosis_Homo sapiens_hsa05131 | 1.73351980 |
| 16 | Malaria_Homo sapiens_hsa05144 | 1.69191378 |
| 17 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.69003843 |
| 18 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.62325238 |
| 19 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.60058375 |
| 20 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.59726755 |
| 21 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.59300003 |
| 22 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.58993189 |
| 23 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.56570237 |
| 24 | Tuberculosis_Homo sapiens_hsa05152 | 1.54408195 |
| 25 | Pertussis_Homo sapiens_hsa05133 | 1.51628942 |
| 26 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.50547683 |
| 27 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.46216363 |
| 28 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.45209263 |
| 29 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.44560409 |
| 30 | Platelet activation_Homo sapiens_hsa04611 | 1.41217021 |
| 31 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.40891952 |
| 32 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.39068848 |
| 33 | Apoptosis_Homo sapiens_hsa04210 | 1.36163198 |
| 34 | Lysosome_Homo sapiens_hsa04142 | 1.35097676 |
| 35 | Hepatitis B_Homo sapiens_hsa05161 | 1.30935702 |
| 36 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.29708437 |
| 37 | Salmonella infection_Homo sapiens_hsa05132 | 1.29422603 |
| 38 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.27910183 |
| 39 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.25599488 |
| 40 | Other glycan degradation_Homo sapiens_hsa00511 | 1.25452473 |
| 41 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.25086073 |
| 42 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.23521201 |
| 43 | Influenza A_Homo sapiens_hsa05164 | 1.19075934 |
| 44 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.14597626 |
| 45 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.14388446 |
| 46 | Viral myocarditis_Homo sapiens_hsa05416 | 1.13906103 |
| 47 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.10301153 |
| 48 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.07630042 |
| 49 | * Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 1.04085970 |
| 50 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.02921987 |
| 51 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.02153330 |
| 52 | Legionellosis_Homo sapiens_hsa05134 | 1.01889728 |
| 53 | Allograft rejection_Homo sapiens_hsa05330 | 1.01144995 |
| 54 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.99904349 |
| 55 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.99245803 |
| 56 | Focal adhesion_Homo sapiens_hsa04510 | 0.98876120 |
| 57 | Amoebiasis_Homo sapiens_hsa05146 | 0.98347418 |
| 58 | Phagosome_Homo sapiens_hsa04145 | 0.98084263 |
| 59 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.96211475 |
| 60 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.94931337 |
| 61 | Asthma_Homo sapiens_hsa05310 | 0.91659838 |
| 62 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.90635803 |
| 63 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.89937297 |
| 64 | Hepatitis C_Homo sapiens_hsa05160 | 0.88834226 |
| 65 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.86454305 |
| 66 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.83921594 |
| 67 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.82708514 |
| 68 | HTLV-I infection_Homo sapiens_hsa05166 | 0.81819144 |
| 69 | Endocytosis_Homo sapiens_hsa04144 | 0.81696422 |
| 70 | Colorectal cancer_Homo sapiens_hsa05210 | 0.81147494 |
| 71 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.79733124 |
| 72 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.76221085 |
| 73 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.73906488 |
| 74 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.71535862 |
| 75 | Glioma_Homo sapiens_hsa05214 | 0.69518371 |
| 76 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.69287628 |
| 77 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.69134768 |
| 78 | Endometrial cancer_Homo sapiens_hsa05213 | 0.66966726 |
| 79 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.66888372 |
| 80 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.66831385 |
| 81 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.66157679 |
| 82 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.66100523 |
| 83 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.65844173 |
| 84 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.65056374 |
| 85 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.64435044 |
| 86 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.64291623 |
| 87 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.62654825 |
| 88 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.60972461 |
| 89 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.60019199 |
| 90 | Prostate cancer_Homo sapiens_hsa05215 | 0.58058588 |
| 91 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.57201936 |
| 92 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.56712221 |
| 93 | Bladder cancer_Homo sapiens_hsa05219 | 0.55960586 |
| 94 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.55062992 |
| 95 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.52696253 |
| 96 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.52131508 |
| 97 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.52127713 |
| 98 | Adherens junction_Homo sapiens_hsa04520 | 0.51300228 |
| 99 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.50907342 |
| 100 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.50872619 |
| 101 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.50854669 |
| 102 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.48900988 |
| 103 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.48805175 |
| 104 | Pathways in cancer_Homo sapiens_hsa05200 | 0.48355059 |
| 105 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.48110625 |
| 106 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.47600409 |
| 107 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.45480242 |
| 108 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.45111125 |
| 109 | Insulin resistance_Homo sapiens_hsa04931 | 0.44524289 |
| 110 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.44506932 |
| 111 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.43632824 |
| 112 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.43549604 |
| 113 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.38511457 |
| 114 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.31055137 |

